Please assess the completion status of the following clinical trial:

Trial Title: BNT001 Digital Therapeutic Feasibility Pilot Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis or history of invasive cancer (excluding non-melanoma skin cancer).~* Patients showing mild to moderate anxiety or depression on the Veteran System Assessment Screen (VSAS), with anxiety or depression scored as 1-6 on a 0-10 scale.~* Fluent in English.~* Has access to iOS or Android smartphone, or tablet and capable of receiving text messages.~* Has an e-mail address.~Exclusion Criteria:~* Endorses thoughts of self-harm, history of suicidality.~* Currently participating in investigative behavioral intervention trial for treatment of anxiety or depression.~* Participant is unable to complete training, has cognitive deficits, major psychiatric conditions, psycho-social conditions; lack of access to reliable internet and accessible device; other social conditions that would interfere with adherence to self directed care, such that in investigator's opinion the participant would be unable to complete the study.~* Recently completed use of Blue Note Therapeutics COVID Cancer Care Program or other Blue Note Therapeutics sponsored study.

- Gender: ALL
- Minimum Age: 17 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- BNT001 (Type: EXPERIMENTAL): BNT001 is a commercially-available, prescription-only, software / medical device in the form of a digital application (digital app) for use on the participant's mobile device which delivers 10-sessions on cognitive behavioral therapy for cancer patients.

Based on this trial design, predict the completion outcome and termination type (if applicable).